Moderate intensity low frequency rotating magnetic field inhibits breast cancer growth in mice

References

• Bender, E., Kozak, K., Howard, S., et al. (2017). The effect of OptuneTM Tumor Treating Fields transducer arrays on skin radiation dose during radiotherapy. J. Clin. Neurosci. 42:172–175. doi 10.1016/j.jocn.2017.04.002
   PubMed Web of Science ®Google Scholar
• Cheng, Y., Muroski, M. E., Petit, D. C. M. C., et al. (2016). Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma. J. Control Release. 223:75–84. doi 10.1016/j.jconrel.2015.12.028
   PubMed Web of Science ®Google Scholar
• Feng, S., Ji, X., and Zhang, X. (2018). Biological effects of moderate intensity extremely low frequency rotating magnetic fields. Chin. J. Biol. 40:309–317.
   Google Scholar
• Jyothi, K. R., Beloor, J., Jo, A., et al. (2015). Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication. Int. J. Nanomedicine. 10:903–921. doi 10.2147/IJN.S74723
   PubMed Web of Science ®Google Scholar
• Li, X., Qin, F., Yang, L., et al. (2014). Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma. Int. J. Nanomedicine. 9:3971–3985. doi 10.2147/IJN.S67343
   PubMed Web of Science ®Google Scholar
• Luo, Y., Ji, X., Liu, J., et al. (2016). Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol. Bioelectrochemistry. 109:31–40. doi 10.1016/j.bioelechem.2016.01.001
   PubMed Web of Science ®Google Scholar
• Maina, V., Sutti, S., Locatelli, I., et al. (2012). Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. Clin. Sci. 122:545–553. doi 10.1042/CS20110366
   PubMed Web of Science ®Google Scholar
• Nie, Y. Z., Chen, Y. Q., Mou, Y. B., et al. (2013a). Low frequency magnetic fields enhance antitumor immune response against mouse H22 hepatocellular carcinoma. PLoS One. 8:e72411. doi 10.1371/journal.pone.0072411
   PubMed Web of Science ®Google Scholar
• Nie, Y. Z., Du, L. L., Mou, Y. B., et al. (2013b). Effect of low frequency magnetic fields on melanoma: Tumor inhibition and immune modulation. Bmc Cancer. 13:582. doi 10.1186/1471-2407-13-582
   PubMed Web of Science ®Google Scholar
• Omar, A. I. (2014). Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma. J. Vis. Exp. 92:e51638.
   Google Scholar
• Ong, Y. S., Saiful Yazan, L., Ng, W. K., et al. (2016). Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice. Int. J. Nanomedicine. 11:5905–5915. doi 10.2147/IJN.S114205
   PubMed Web of Science ®Google Scholar
• Pavesi, A., Adriani, G., Tay, A., et al. (2016). Engineering a 3D microfluidic culture platform for tumor-treating field application. Sci. Rep. 6:26584. doi 10.1038/srep26584
   PubMed Web of Science ®Google Scholar
• Ren, J., Ding, L., Xu, Q. Y., et al. (2017). LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1/E2F3 pathway. Sci. Rep. 7:749. doi 10.1038/s41598-017-00913-2
   PubMed Web of Science ®Google Scholar
• Shen, Y. J., Wu, C. Y., Uyeda, T. Q. P., et al. (2017). Elongated nanoparticle aggregates in cancer cells for mechanical destruction with low frequency rotating magnetic field. Theranostics. 7:1735–1748. doi 10.7150/thno.18352
   PubMed Web of Science ®Google Scholar
• Straube, C., Oechsner, M., Kampfer, S., et al. (2018). Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas - a planning study. Radiat. Oncol. 13:31. doi 10.1186/s13014-018-0976-3
   PubMed Web of Science ®Google Scholar
• Sun, C. T., Yu, H. M., Wang, X. W., and Han, J. Q. (2012). A pilot study of extremely low-frequency magnetic fields in advanced non-small cell lung cancer: Effects on survival and palliation of general symptoms. Oncol. Lett. 4:1130–1134. doi 10.3892/ol.2012.867
   PubMed Web of Science ®Google Scholar
• Tarao, K., Rino, Y., Ohkawa, S., et al. (1999). Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer. 86:589–595.
   PubMed Web of Science ®Google Scholar
• Tarao, K., Takemiya, S., Tamai, S., et al. (1997). Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer. 79:688–694.
   PubMed Web of Science ®Google Scholar
• Tian, X., Wang, D., Zha, M., et al. (2018). Magnetic field direction differentially impacts the growth of different cell types. Electromagn. Biol. Med. 37:114–125. doi 10.1080/15368378.2018.1458627
   PubMed Web of Science ®Google Scholar
• Wang, T., Nie, Y., Zhao, S., et al. (2011). Involvement of midkine expression in the inhibitory effects of low-frequency magnetic fields on cancer cells. Bioelectromagnetics. 32:443–452. doi 10.1002/bem.20654
   PubMed Web of Science ®Google Scholar
• Zhang, L., Ji, X., Yang, X., and Zhang, X. (2017). Cell type- and density-dependent effect of 1 T static magnetic field on cell proliferation. Oncotarget. 8:13126–13141. doi 10.18632/oncotarget.14480
   PubMedGoogle Scholar
• Zhang, L., Wang, J., Wang, H., et al. (2016). Moderate and strong static magnetic fields directly affect EGFR kinase domain orientation to inhibit cancer cell proliferation. Oncotarget. 7:41527–41539. doi 10.18632/oncotarget.9479
   PubMedGoogle Scholar
• Zhang, L., Yang, X., Liu, J., et al. (2015). 1T moderate intensity static magnetic field affects Akt/mTOR pathway and increases the antitumor efficacy of mTOR inhibitors in CNE-2Z cells. Sci. Bull. 60:2120–2128. doi 10.1007/s11434-015-0950-5
   Web of Science ®Google Scholar